Case Report: A Novel Compound Heterozygous Mutation in IL-10RA in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease.
Case Report: A Novel Compound Heterozygous Mutation in IL-10RA in a Chinese Child With Very Early-Onset Inflammatory Bowel Disease.
复制标题
病例报告:一名患有极早发性炎症性肠病的中国儿童 IL-10RA 中的新型复合杂合突变
DOI:
10.3389/fped.2021.678390
复制
发表时间:
2021
影响因子:
2.6
通讯作者:
Wang Y
中科院分区:
文献类型:
--
作者:
Dong F;Xiao F;Ge T;Li X;Xu W;Wu S;Zhang T;Wang Y
Very early-onset inflammatory bowel disease (VEO-IBD) is defined as IBD diagnosed in children younger than 6 years of age. VEO-IBD is often associated with a monogenic etiology or primary immune deficiency. Here, we report the case of a 7-month-old Chinese girl diagnosed with VEO-IBD who had a variant in the interleukin-10 receptor A (IL-10-RA) gene. The patient presented with recurrent fevers, abdominal pain, diarrhea, perianal abscesses, and oral ulcers. Whole-exome sequencing (WES) identified a novel compound heterozygote mutation, c.395T>G (p.Leu132Arg)/ex.1del (p.?), in the IL-10RA gene of the patient. The missense mutation c.395T>G (p.Leu132Arg) was inherited from her mother, and ex.1del (p.?) was inherited from her father. Neither mutation has been reported previously. The IL-10RA function of the patient was defective, as demonstrated by a failure of signal transducer and activator of transcription 3 (STAT3) activation in peripheral blood mononuclear cells (PBMCs) stimulated with recombinant IL-10. The patient underwent matched unrelated peripheral blood hematopoietic stem cell transplantation (HSCT), and the clinical manifestations were dramatically improved. In summary, we identified a novel compound heterozygote mutation, c.395T>G (p.Leu132Arg)/ex.1del (p.?), in IL-10RA that caused VEO-IBD in a Chinese child, which further expands the mutational spectrum of IL-10RA.
登录
查看更多内容
DOI:
10.1038/ajg.2017.97
发表时间:
2017-07
期刊:
The American journal of gastroenterology
影响因子:
--
作者:
Benchimol EI;Bernstein CN;Bitton A;Carroll MW;Singh H;Otley AR;Vutcovici M;El-Matary W;Nguyen GC;Griffiths AM;Mack DR;Jacobson K;Mojaverian N;Tanyingoh D;Cui Y;Nugent ZJ;Coulombe J;Targownik LE;Jones JL;Leddin D;Murthy SK;Kaplan GG
通讯作者:
Kaplan GG
影响因子:
29.4
作者:
Uhlig HH;Schwerd T;Koletzko S;Shah N;Kammermeier J;Elkadri A;Ouahed J;Wilson DC;Travis SP;Turner D;Klein C;Snapper SB;Muise AM;COLORS in IBD Study Group and NEOPICS
通讯作者:
COLORS in IBD Study Group and NEOPICS
影响因子:
3.5
作者:
Shim, Jung Ok;Seo, Jeong Kee
通讯作者:
Seo, Jeong Kee
影响因子:
9.8
作者:
Begue, Bernadette;Verdier, Julien;Ruemmele, Frank M.
通讯作者:
Ruemmele, Frank M.
影响因子:
29.4
作者:
Kotlarz, Daniel;Beier, Rita;Klein, Christoph
通讯作者:
Klein, Christoph